Affect Therapeutics is a digital therapeutic provider that offers digital treatments solutions for both alcohol and substance abuse. The company’s solution, Affect, operates via an app and provides users with daily challenges to encourage sobriety and a healthy lifestyle. The app also has in-built functions to offer users one-on-one sessions with counselors, access to therapy groups, psychiatric consultations, and periodic drug/alcohol screenings. The app utilizes gamified mechanics, including providing monetary rewards for completing tasks and additional rewards for maintaining and 'streaks' of sobriety, to improve user stickiness. The company provides a variety of treatment plans to encourage users to quit habit forming substances such as alcohol, marijuana, meth, cocaine, or prescription stimulants.
Key customers and partnerships
The company operates both on a D2C basis as well as a B2B2C basis, working with healthcare providers to offer its solution to users while accepting most health plans for access. As of July 2023, the company has outpatient treatment licenses in 20 states and aims to cover a majority of the US population by the end of 2023.
As of September 2024, the company had secured several partnerships with major health plans such as UnitedHealthcare, Aetna, Humana, Molina, and Centene.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.